Prestige Consumer Healthcare
378 hedge funds and large institutions have $4.16B invested in Prestige Consumer Healthcare in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 151 increasing their positions, 119 reducing their positions, and 32 closing their positions.
72% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 32
27% more repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 119
5% more funds holding
Funds holding: 359 → 378 (+19)
0.92% more ownership
Funds ownership: 104.4% → 105.31% (+0.92%)
6% less capital invested
Capital invested by funds: $4.44B → $4.16B (-$288M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$42.5M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$24.8M |
| 3 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$14.1M |
| 4 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$12.3M |
| 5 |
EP
Edgestream Partners
Princeton,
New Jersey
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$45.7M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$26.5M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$23.9M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$20.4M |
| 5 |
BlackRock
New York
|
-$18M |
PBH Hedge Fund Activity: Q2 2025 in Review
378 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2025, worth a combined $4.16B — down 6.5% from $4.44B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PBH positions and 32 closed out — a net gain of 23 holders — while 151 added to existing stakes and 119 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $42.5M. The largest seller was Victory Capital Management, cutting an estimated $45.7M.
- 378 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2025, up from 359 in Q1 2025.
- Funds reported $4.16B of Prestige Consumer Healthcare stock for Q2 2025, down 6.5% quarter-over-quarter.
- 55 funds opened new Prestige Consumer Healthcare positions in Q2 2025 and 32 closed out, a net change of +23 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2025 was Goldman Sachs, an estimated $42.5M added.
- The largest Prestige Consumer Healthcare seller in Q2 2025 was Victory Capital Management, an estimated $45.7M sold.
Based on aggregated 13F filings for Q2 2025.